18F-FLT positron emission tomography (PET) is a pharmacodynamic marker for EWS-FLI1 activity and Ewing sarcoma

Christy L. Osgood, Mohammed N. Tantawy, Nichole Maloney, Zachary B. Madaj, Anderson Peck, Elissa Boguslawski, Jennifer Jess, Jason Buck, Mary E. Winn, H. Charles Manning, Patrick J. Grohar

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of '18F-FLT positron emission tomography (PET) is a pharmacodynamic marker for EWS-FLI1 activity and Ewing sarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences